Disease | glomerulosclerosis |
Phenotype | C0011847|diabetes |
Sentences | 9 |
PubMedID- 21521871 | The glomerular podocyte is believed to play a role in the development and progression of albuminuria and glomerulosclerosis associated with diabetes (1–3,30). |
PubMedID- 20382513 | These results demonstrate that extracts from roasted licorice may be highly potent therapeutic agents for the prevention and treatment of mesangial fibrosis and glomerulosclerosis leading to diabetes nephropathy due to longstanding diabetes mellitus. |
PubMedID- 22448165 | The glomerular podocyte plays a key role in the development and progression of albuminuria and glomerulosclerosis associated with diabetes [66–69]. |
PubMedID- 24744899 | These observations suggest that adiponectin treatment reduces glomerulosclerosis resulting from type ii diabetes probably through its anti-inflammatory and angiotensin-antagonistic effects. |
PubMedID- 24152508 | Focal segmental glomerulosclerosis associated with maternally inherited diabetes and deafness: clinical pathological analysis. |
PubMedID- 21703397 | Monocyte/ chemoattractant protein-1/chemokine ligand (ccl) 2 and stromal cell-derived factor-1/cxcl12 both contribute to glomerulosclerosis in mice with type 2 diabetes mellitus, through different mechanisms. |
PubMedID- 23768159 | The glomerular podocyte is believed to play a role in the development and progression of albuminuria and glomerulosclerosis associated with diabetes, among other [27,28]. |
PubMedID- 24195695 | Thus high doses of valsartan not only reduce albuminuria maximally, but also halt the progression of the glomerulosclerosis resulting from type 2 diabetes via a reduction in podocyte injury and renal oxidative stress and inflammation. |
PubMedID- 26239683 | There is another aspect that has emerged during these years and that is the existence of diffuse glomerulosclerosis cases in patients without diabetes, which resembles class ii dn [13]. |
Page: 1